Assessment of topical steroid phobia in dermatology patients, a cross-sectional study from an urban area of Pakistan

Masood, Sadia; Jalil, Palwasha; Awan, Safia; Ghulam, Unzela; Kerawala, Sabeika Raza

doi:10.1080/09546634.2021.1959505

Cited by 3 publications

(4 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results we obtained through this research showed that the Croatian version of the TOPICOP questionnaire has sufficient validity and reliability. Our findings are comparable to the results of the validation studies across other populations, which have likewise discovered the questionnaire’s excellent psychometric qualities [ 3 , 24 , 25 , 36 , 37 , 44 , 45 , 46 , 47 , 48 , 49 ]. Despite the corticophobia prevalence being comparable to other similar studies, the gender distribution does not align with previous findings that indicate a higher frequency in female individuals [ 23 ].…”

Section: Discussionsupporting

confidence: 89%

Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire

Markota Čagalj,

Markic,

Vuković

et al. 2024

Medicina

View full text Add to dashboard Cite

Background and Objectives: This study demonstrates the factor structure and reliability of the Croatian version of the TOPICOP (Topical Corticosteroid Phobia) questionnaire, thereby contributing to further validation and standardization of the measurement of topical corticophobia with dermatological patients or their parents, which directly affects patient or parent compliance, as well as the final therapeutic effect. Materials and Methods: The cross-sectional, observational study was conducted at the University Hospital Centre Split, Department of Dermatovenerology. The research involved inviting 120 participants (age 12–68) who attended the University Hospital Centre Split’s Atopy School, patients examined in the Dermatology Outpatient Clinic of the University Hospital Centre Split and diagnosed with atopic dermatitis (AD) or allergic contact dermatitis (ACD), and parents or legal representatives of patients younger than 12 years old. The TOPICOP questionnaire consists of 12 items assessing the three different components of topical corticophobia (worries, beliefs, and behaviour). Respondents evaluated their perception of the correctness of each statement within 10 min of filling out the questionnaire on a four-point Likert scale. Results: The response rate was 94%, resulting in a sample of 113 respondents (109 adults and 4 children). Factor analysis yielded one common factor of relatively high reliability (Cronbach α = 0.85, 95% CI 0.81 to 0.89). No differences were found in questionnaire scores between male and female participants, nor between the parents/legal representatives of dermatological patients and other patients. Conclusions: This research contributes to further development of the appropriate measuring instrument, its practical application, and thus, the better recognition, resolution, and prevention of topical corticophobia as part of the better overall healthcare and treatment of chronic dermatological patients.

show abstract

Section: Discussionsupporting

confidence: 89%

Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire

Markota Čagalj,

Markic,

Vuković

et al. 2024

Medicina

View full text Add to dashboard Cite

show abstract

“…In this study, the prevalence of steroid phobia was approximately 37% and 12% in caregivers and adolescents, respectively. The median global TOPICOP© score of caregivers in our study was comparable to the studies from Japan (mean 40.3 ± 16.7%), 4 France (mean 37.0%), 5 Singapore (median 44.4%) 6 and was much higher than the study from Pakistan (median 18.0%) 7 . Participants in this study acknowledged less non‐adherence to treatment than patients in the study from France 5 …”

Section: Discussionsupporting

confidence: 65%

“…The median global TOPICOP© score of caregivers in our study was comparable to the studies from Japan (mean 40.3 ± 16.7%), 4 France (mean 37.0%), 5 Singapore (median 44.4%) 6 and was much higher than the study from Pakistan (median 18.0%). 7 Participants in this study acknowledged less non-adherence to treatment than patients in the study from France. 5 Receiving information about TCS from dermatologists, absence of flare within the past year and longer duration of treatment under pediatric dermatologists' supervision were significantly correlated to a lower prevalence of steroid phobia.…”

Section: Discussionmentioning

confidence: 88%

Topical corticosteroid phobia in adolescents with eczema and caregivers of children and adolescents with eczema: A cross‐sectional survey

Tangthanapalakul

Chantawarangul

Wananukul

et al. 2022

Pediatric Dermatology

View full text Add to dashboard Cite

Steroid phobia is an increasing phenomenon that affects treatment adherence. The purpose of this study was to assess the prevalence and associated factors of steroid phobia among adolescents with eczema and the caregivers of children and adolescents with eczema by using questionnaires and TOPICOP© scale. The prevalence of steroid phobia is approximately 12% and 37% in the adolescent and caregiver groups, respectively. Caregivers who obtained information about topical corticosteroid (TCS) from dermatologists and whose children had fewer number of flares, demonstrated less concern about using TCS.

show abstract

“…Despite diminished TCS concerns, caregivers adhered to appropriate TCS application instructions, as the usage of TCS for more than Female caregivers and shorter duration of TCS use (2 weeks to 3 months) were associated with higher levels of TCS concerns, as indicated by recent studies. 9,11,16 Caregivers with more disease experience, adequate information from healthcare professionals, and no side effects from prolonged TCS use showed lower levels of concerns.…”

Section: Discussionmentioning

confidence: 99%

Unveiling the potential: Enhancing caregiver knowledge through video education to address topical corticosteroid concerns in children with eczematous dermatitis

Sitthisan,

Wananukul,

Chatproedprai

et al. 2023

Pediatric Dermatology

View full text Add to dashboard Cite

BackgroundConcerns about the use of topical corticosteroids (TCS) in pediatric eczematous dermatitis management often hinder effective treatment. Limited data exist regarding the prevalence of these concerns and the effectiveness of interventions. This study aimed to assess the prevalence of TCS concerns among caregivers and determine the effectiveness of video education in mitigating these concerns.MethodsA single‐center prospective study was conducted from 2022 to 2023, involving caregivers of children under 18 years with eczematous dermatitis. Baseline and post‐intervention questionnaires were administered after a 4‐week period. Caregivers received video education on TCS use, and the TOPICOP score was evaluated before and after viewing the video.ResultsThe study included 150 caregivers, 85.3% female and 74% had a child with atopic dermatitis. The prevalence of TCS concerns among Thai caregivers was 62%. Following video education, the prevalence of TCS concerns significantly decreased to 10.7%. Mean belief score decreased from 43.81 ± 13.45 to 31.85 ± 16.56, mean worry score decreased from 56.22 ± 18.27 to 40.41 ± 18.55 and mean total TOPICOP score decreased from 50.02 ± 12.65 to 36.13 ± 13.52 (p‐value <.001). The intervention also resulted in reduced disease exacerbations, duration of the rash, and duration of TCS use. The optimal TOPICOP cut‐off score to predict TCS concerns was identified as 43.06.ConclusionVideo education effectively alleviated TCS concerns among caregivers, addressing beliefs, worries, disease exacerbations, and side effects. Integration of this intervention into the management of pediatric eczematous dermatitis can yield optimal outcomes.

show abstract

Assessment of topical steroid phobia in dermatology patients, a cross-sectional study from an urban area of Pakistan

Cited by 3 publications

References 19 publications

Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire

Linguistic Validation and Reliability of the Croatian Version of the TOPICOP Questionnaire

Topical corticosteroid phobia in adolescents with eczema and caregivers of children and adolescents with eczema: A cross‐sectional survey

Unveiling the potential: Enhancing caregiver knowledge through video education to address topical corticosteroid concerns in children with eczematous dermatitis

Contact Info

Product

Resources

About